Comparative analysis of adverse hematologic effects in 135 patients with with chronic hepatits C on combined antiviral therapy of pegylated and "short lived" forms of alpha-interferon in combination with ribavirin was investigated. As a result of the comparison, the response to antiviral therapy in patients with chronic hepatitis C treated with daily administration of simple interferon-alpha in hematologic data is similar in patients undergoing treatment with pegylated drugs.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients chronic
8
antiviral therapy
8
[pegylated intereferon
4
intereferon hematological
4
hematological safety
4
safety comparison
4
comparison standard]
4
standard] comparative
4
comparative analysis
4
analysis adverse
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!